Research & Literature

Surgery for gallbladder cancer in the US: a need for greater lymph node clearance.

Tran TB, Nissen NN

Journal of gastrointestinal oncology 2015; (6(5)):452-8 doi:10.3978/j.issn.2078-6891.2015.062.

[Operation treatment method of Bismuth-Corlette Ⅲ, Ⅳ hilar cholangiocarcinoma].

Lu Z, Wang DD

Zhonghua wai ke za zhi [Chinese journal of surgery] 2016; (54(7)):488-91 doi:10.3760/cma.j.issn.0529-5815.2016.07.003.

HER2/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target?

Galdy S, Lamarca A, McNamara MG, et al.

Cancer metastasis reviews 2017; (36(1)):141-157 doi:10.1007/s10555-016-9645-x.

Mutation Profile and Fluorescence In Situ Hybridization Analyses Increase Detection of Malignancies in Biliary Strictures.

Gonda TA, Viterbo D, Gausman V, et al.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2017; (15(6)):913-919.e1 doi:10.1016/j.cgh.2016.12.013.

Evaluation of Tumor Markers and Their Impact on Prognosis in Gallbladder, Bile Duct and Cholangiocellular Carcinomas - A Pilot Study.

Liska V, Treska V, Skalicky T, et al.

Anticancer research 2017; (37(4)):2003-2009 doi:10.21873/anticanres.11544.

Do hepatic-sided tumors require more extensive resection than peritoneal-sided tumors in patients with T2 gallbladder cancer? Results of a retrospective multicenter study.

Lee W, Jeong CY, Jang JY, et al.

Surgery 2017; (162(3)):515-524 doi:10.1016/j.surg.2017.05.004.

Cholangiocarcinoma and its mimickers in primary sclerosing cholangitis.

Lee JJ, Schindera ST, Jang HJ, et al.

Abdominal radiology (New York) 2017; (42(12)):2898-2908 doi:10.1007/s00261-017-1328-8.

Clinical epidemiological survey of gallbladder carcinoma in northwestern China, 2009-2013: 2379 cases in 17 centers.

Shen HX, Song HW, Xu XJ, et al.

Chronic diseases and translational medicine 2017; (3(1)):60-66 doi:10.1016/j.cdtm.2017.01.003.

Prognostic predictability of the new American Joint Committee on Cancer 8th staging system for distal bile duct cancer: limited usefulness compared with the 7th staging system.

Kang JS, Lee S, Son D, et al.

Journal of hepato-biliary-pancreatic sciences 2018; (25(2)):124-130 doi:10.1002/jhbp.520.

Recurrence after curative-intent resection of perihilar cholangiocarcinoma: analysis of a large cohort with a close postoperative follow-up approach.

Komaya K, Ebata T, Yokoyama Y, et al.

Surgery 2018; (163(4)):732-738 doi:10.1016/j.surg.2017.08.011.

Long-term follow-up and risk factors for strictures after hepaticojejunostomy for bile duct injury: An analysis of surgical and percutaneous treatment in a tertiary center.

Booij KAC, Coelen RJ, de Reuver PR, et al.

Surgery 2018; (163(5)):1121-1127 doi:10.1016/j.surg.2018.01.003.

The optimal surgical resection approach for T2 gallbladder carcinoma: evaluating the role of surgical extent according to the tumor location.

Park TJ, Ahn KS, Kim YH, et al.

Annals of surgical treatment and research 2018; (94(3)):135-141 doi:10.4174/astr.2018.94.3.135.

[Clinical, epidemiological and therapeutic features of biliary tract cancers: about 20 cases].

Ka I, Faye M, Diop PS, et al.

The Pan African medical journal 2018; (29()):13 doi:10.11604/pamj.2018.29.13.9922.

EUS-FNA versus ERCP for tissue diagnosis of suspect malignant biliary strictures: a prospective comparative study.

Moura DTH, de Moura EGH, Matuguma SE, et al.

Endoscopy international open 2018; (6(6)):E769-E777 doi:10.1055/s-0043-123186.

Risk Factors for Post Endoscopic Retrograde Cholangiopancreatography Cholangitis

Boonsinsukh T, Viriyaroj V, Yodying H

Journal of the Medical Association of Thailand = Chotmaihet thangphaet 2016; (99 Suppl 8()):S166-S170.

Surgical management of hilar cholangiocarcinoma at Memorial Sloan Kettering Cancer Center.

Lidsky ME, Jarnagin WR

Annals of gastroenterological surgery 2018; (2(4)):304-312 doi:10.1002/ags3.12181.

Gallbladder cancer in Eastern Province of Saudi Arabia: A retrospective cohort study.

Aldossary MY, Alayed AA, Amr SS, et al.

Annals of medicine and surgery (2012) 2018; (35()):117-123 doi:10.1016/j.amsu.2018.09.020.

Adjuvant Therapy for Biliary Tract Cancers.

Horgan AM, Knox JJ

Journal of oncology practice 2018; (14(12)):701-708 doi:10.1200/JOP.18.00558.

Longitudinal analysis of CA19-9 reveals individualised normal range and early changes before development of biliary tract cancer in patients with primary sclerosing cholangitis.

Wannhoff A, Brune M, Knierim J, et al.

Alimentary pharmacology & therapeutics 2019; (49(6)):769-778 doi:10.1111/apt.15146.

Positive cystic duct margin at index cholecystectomy in incidental gallbladder cancer is an important negative prognosticator.

Vega EA, Vinuela E, Sanhueza M, et al.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2019; (45(6)):1061-1068 doi:10.1016/j.ejso.2019.01.013.

Gallbladder Cancer: Diagnosis, Surgical Management, and Adjuvant Therapies.

Hickman L, Contreras C

The Surgical clinics of North America 2019; (99(2)):337-355 doi:10.1016/j.suc.2018.12.008.

Dealing with insufficient liver remnant: Associating liver partition and portal vein ligation for staged hepatectomy.

Linecker M, Kuemmerli C, Clavien PA, Petrowsky H

Journal of surgical oncology 2019; (119(5)):604-612 doi:10.1002/jso.25435.

Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline.

Shroff RT, Kennedy EB, Bachini M, et al.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2019; (37(12)):1015-1027 doi:10.1200/JCO.18.02178.

Calcified gallbladder cancer: is it preventable?

Thakrar R, Monib S, Pakdemirli E, Thomson S

Journal of surgical case reports 2019; (2019(3)):rjz069 doi:10.1093/jscr/rjz069.

Lymphatic spread of T2 gallbladder carcinoma: Regional lymphadenectomy is required independent of tumor location.

Toge K, Sakata J, Hirose Y, et al.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2019; (45(8)):1446-1452 doi:10.1016/j.ejso.2019.03.038.

Increased multimodality treatment options has improved survival for Hepatocellular carcinoma but poor survival for biliary tract cancers remains unchanged.

Alabraba E, Joshi H, Bird N, et al.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2019; (45(9)):1660-1667 doi:10.1016/j.ejso.2019.04.002.

[Paying attention to the diagnosis and treatment of IgG4-related sclerosing cholangitis].

Li BL, Xiao JC

Zhonghua wai ke za zhi [Chinese journal of surgery] 2019; (57(7)):508-512 doi:10.3760/cma.j.issn.0529-5815.2019.07.006.

Common bile duct stone development due to a Hem-o-lok clip migration: a rare complication of laparoscopic cholecystectomy.

Roh YJ, Kim JW, Jeon TJ, Park JY

BMJ case reports 2019; (12(7)) doi:10.1136/bcr-2019-230178.

Cholangioscopy Biopsies Improve Detection of Cholangiocarcinoma When Combined with Cytology and FISH, but Not in Patients with PSC.

Kaura K, Sawas T, Bazerbachi F, et al.

Digestive diseases and sciences 2020; (65(5)):1471-1478 doi:10.1007/s10620-019-05866-2.

Hospital Surgical Volume and 3-Year Mortality in Severe Prognosis Cancers: A Population-Based Study Using Cancer Registry Data.

Taniyama Y, Tabuchi T, Ohno Y, et al.

Journal of epidemiology 2021; (31(1)):52-58 doi:10.2188/jea.JE20190242.

ASO Author Reflections: Essential to Reduce Adverse Outcomes in Perihilar Cholangiocarcinoma Surgery-Portal Vein Embolization.

Olthof PB, van Gulik TM

Annals of surgical oncology 2020; (27(7)):2319-2320 doi:10.1245/s10434-020-08333-9.

Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study.

Abou-Alfa GK, Sahai V, Hollebecque A, et al.

The Lancet. Oncology 2020; (21(5)):671-684 doi:10.1016/S1470-2045(20)30109-1.

Volume-outcome relationship of liver surgery: a nationwide analysis.

Olthof PB, Elfrink AKE, Marra E, et al.

The British journal of surgery 2020; (107(7)):917-926 doi:10.1002/bjs.11586.

The 8th Edition American Joint Committee on Cancer Staging for Hepato-pancreato-biliary Cancer: A Review and Update.

Liao X, Zhang D

Archives of pathology & laboratory medicine 2021; (145(5)):543-553 doi:10.5858/arpa.2020-0032-RA.

Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE-158 and KEYNOTE-028 studies.

Piha-Paul SA, Oh DY, Ueno M, et al.

International journal of cancer 2020; (147(8)):2190-2198 doi:10.1002/ijc.33013.

Gallbladder Cancer: Imaging Appearance and Pitfalls in Diagnosis.

John S, Moyana T, Shabana W, et al.

Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes 2020; (71(4)):448-458 doi:10.1177/0846537120923273.

Cholangiocarcinoma: Diagnosis and Management.

Buckholz AP, Brown RS

Clinics in liver disease 2020; (24(3)):421-436 doi:10.1016/j.cld.2020.04.005.

Comprehensive genomic landscape and precision therapeutic approach in biliary tract cancers.

Okamura R, Kurzrock R, Mallory RJ, et al.

International journal of cancer 2021; (148(3)):702-712 doi:10.1002/ijc.33230.

Genetic analysis in the clinical management of biliary tract cancer.

Wakai T, Nagahashi M, Shimada Y, et al.

Annals of gastroenterological surgery 2020; (4(4)):316-323 doi:10.1002/ags3.12334.

Systemic treatment options for advanced biliary tract carcinoma.

Xie C, McGrath NA, Monge Bonilla C, Fu J

Journal of gastroenterology 2020; (55(10)):944-957 doi:10.1007/s00535-020-01712-9.

Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial.

Subbiah V, Lassen U, Élez E, et al.

The Lancet. Oncology 2020; (21(9)):1234-1243 doi:10.1016/S1470-2045(20)30321-1.

Survival analysis of patients with stage T2a and T2b perihilar cholangiocarcinoma treated with radical resection.

Zhao J, Zhang W, Zhang J, et al.

BMC cancer 2020; (20(1)):849 doi:10.1186/s12885-020-07357-4.

Effect of preoperative jaundice on long-term prognosis of gallbladder carcinoma with radical resection.

Yang XW, Chen JY, Wen ZJ, et al.

World journal of surgical oncology 2020; (18(1)):239 doi:10.1186/s12957-020-02015-2.

Prognostic Relevance of the Eighth Edition of TNM Classification for Resected Perihilar Cholangiocarcinoma.

Hau HM, Meyer F, Jahn N, et al.

Journal of clinical medicine 2020; (9(10)) doi:10.3390/jcm9103152.

Isolated IgG4-related sclerosing cholangitis with normal serum IgG4 levels-A case report.

Shu Y, Cheng J, Ye J, Pan X

Clinical case reports 2020; (8(11)):2186-2190 doi:10.1002/ccr3.3083.

Quality of Life and Mental Health in Mothers and Fathers Caring for Children and Adolescents with Rare Diseases Requiring Long-Term Mechanical Ventilation.

Boettcher J, Denecke J, Barkmann C, Wiegand-Grefe S

International journal of environmental research and public health 2020; (17(23)) doi:10.3390/ijerph17238975.

Biliary tract cancer.

Valle JW, Kelley RK, Nervi B, et al.

Lancet (London, England) 2021; (397(10272)):428-444 doi:10.1016/S0140-6736(21)00153-7.

Conditional Recurrence-Free Survival for Patients with Gallbladder Cancer: A Personalized Resource for Patients and Providers.

Ejaz A, Pawlik TM

Annals of surgical oncology 2021; (28(5)):2436-2437 doi:10.1245/s10434-021-09629-0.

Validation of the 8th Edition American Joint Commission on Cancer (AJCC) Gallbladder Cancer Staging System: Prognostic Discrimination and Identification of Key Predictive Factors.

Giannis D, Cerullo M, Moris D, et al.

Cancers 2021; (13(3)) doi:10.3390/cancers13030547.

Gallbladder carcinoma outcomes in an Australian tertiary referral hospital.

Wietsma MFT, Molloy C, Bhimani N, et al.

ANZ journal of surgery 2021; (91(4)):603-608 doi:10.1111/ans.16663.

Novel Targeted Therapies for Advanced Cholangiocarcinoma.

Rizzo A, Brandi G

Medicina (Kaunas, Lithuania) 2021; (57(3)) doi:10.3390/medicina57030212.

Targeting FGFR in intrahepatic cholangiocarcinoma [iCCA]: leading the way for precision medicine in biliary tract cancer [BTC]?

Aitcheson G, Mahipal A, John BV

Expert opinion on investigational drugs 2021; (30(4)):463-477 doi:10.1080/13543784.2021.1900821.

[Related factors for bile duct infection after surgical treatment of biliary dilatation].

Wu X, Li ZJ, Zheng W, et al.

Zhonghua wai ke za zhi [Chinese journal of surgery] 2021; (59(4)):284-288 doi:10.3760/cma.j.cn112139-20201229-00890.

Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial.

Lamarca A, Palmer DH, Wasan HS, et al.

The Lancet. Oncology 2021; (22(5)):690-701 doi:10.1016/S1470-2045(21)00027-9.

Chemotherapy for advanced gallbladder cancer (GBC): A systematic review and meta-analysis.

Azizi AA, Lamarca A, McNamara MG, Valle JW

Critical reviews in oncology/hematology 2021; (163()):103328 doi:10.1016/j.critrevonc.2021.103328.

Current challenges to underpinning the genetic basis for cholangiocarcinoma.

Cigliano A, Chen X, Calvisi DF

Expert review of gastroenterology & hepatology 2021; (15(5)):511-526 doi:10.1080/17474124.2021.1915128.

Serum Dickkopf-1 in Combined with CA 19-9 as a Biomarker of Intrahepatic Cholangiocarcinoma.

Kim SY, Lee HS, Bang SM, et al.

Cancers 2021; (13(8)) doi:10.3390/cancers13081828.

External validation study of the 8th edition of the American Joint Committee on Cancer staging system for perihilar cholangiocarcinoma: a single-center experience in China and proposal for simplification.

Zhao J, Zhang W, Zhang J, et al.

Journal of gastrointestinal oncology 2021; (12(2)):806-818 doi:10.21037/jgo-20-348.

Chemotherapy for Biliary Tract Cancer in 2021.

Sasaki T, Takeda T, Okamoto T, et al.

Journal of clinical medicine 2021; (10(14)) doi:10.3390/jcm10143108.

Expression of HER2 and Mismatch Repair Proteins in Surgically Resected Gallbladder Adenocarcinoma.

Sung YN, Kim SJ, Jun SY, et al.

Frontiers in oncology 2021; (11()):658564 doi:10.3389/fonc.2021.658564.

Clinical and Image Characteristics of IgG4-Related Sclerosing Cholecystitis.

Kuwatani M, Sakamoto N

Diagnostics (Basel, Switzerland) 2021; (11(8)) doi:10.3390/diagnostics11081358.

Single-center experience of liver transplantation for perihilar cholangiocarcinoma.

Ahmed O, Vachharajani N, Chang SH, et al.

HPB : the official journal of the International Hepato Pancreato Biliary Association 2022; (24(4)):461-469 doi:10.1016/j.hpb.2021.08.940.

Survival Benefits of Simple Versus Extended Cholecystectomy and Lymphadenectomy for Patients With T2 Gallbladder Cancer: A Propensity-Matched Population-Based Study (2010 to 2015).

Zhang W, Huang Z, Wang WE, Che X

Frontiers in oncology 2021; (11()):705299 doi:10.3389/fonc.2021.705299.

Current and emerging therapies for advanced biliary tract cancers.

Kam AE, Masood A, Shroff RT

The lancet. Gastroenterology & hepatology 2021; (6(11)):956-969 doi:10.1016/S2468-1253(21)00171-0.

Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and leucovorin for metastatic biliary tract cancer after progression on gemcitabine plus cisplatin (NIFTY): a multicentre, open-label, randomised, phase 2b study.

Yoo C, Kim KP, Jeong JH, et al.

The Lancet. Oncology 2021; (22(11)):1560-1572 doi:10.1016/S1470-2045(21)00486-1.

Comparison of EUS and ERCP-guided tissue sampling in suspected biliary stricture.

Chung HG, Chang JI, Lee KH, et al.

PloS one 2021; (16(10)):e0258887 doi:10.1371/journal.pone.0258887.

Isolated mass-forming IgG4-related sclerosing cholangitis masquerading as extrahepatic cholangiocarcinoma: A case report.

Song S, Jo S

World journal of clinical cases 2021; (9(29)):8773-8781 doi:10.12998/wjcc.v9.i29.8773.

Quality of life and mental health of children with rare congenital surgical diseases and their parents during the COVID-19 pandemic.

Fuerboeter M, Boettcher J, Barkmann C, et al.

Orphanet journal of rare diseases 2021; (16(1)):498 doi:10.1186/s13023-021-02129-0.

Dual HER2 Blockade: An Emerging Option in Metastatic Biliary Tract Cancer?

Ricci AD, Rizzo A

Medicina (Kaunas, Lithuania) 2021; (57(12)) doi:10.3390/medicina57121301.

Facebook Support Groups for Pediatric Rare Diseases: Cross-Sectional Study to Investigate Opportunities, Limitations, and Privacy Concerns.

Titgemeyer SC, Schaaf CP

JMIR pediatrics and parenting 2022; (5(1)):e31411 doi:10.2196/31411.

Importance of Normalization of Carbohydrate Antigen 19-9 in Patients With Intrahepatic Cholangiocarcinoma.

Li H, Feng Y, Liu C, et al.

Frontiers in oncology 2021; (11()):780455 doi:10.3389/fonc.2021.780455.

How I treat biliary tract cancer.

Lamarca A, Edeline J, Goyal L

ESMO open 2022; (7(1)):100378 doi:10.1016/j.esmoop.2021.100378.

Case Report: Addition of PD-1 Antibody Camrelizumab Overcame Resistance to Trastuzumab Plus Chemotherapy in a HER2-Positive, Metastatic Gallbladder Cancer Patient.

Wang L, Li X, Cheng Y, et al.

Frontiers in immunology 2021; (12()):784861 doi:10.3389/fimmu.2021.784861.

Adjuvant treatment in biliary tract cancer.

Palloni A, Frega G, De Lorenzo S, et al.

Translational cancer research 2019; (8(Suppl 3)):S289-S296 doi:10.21037/tcr.2018.08.17.

Isolated IgG4-related cholecystitis with localized gallbladder wall thickening mimicking gallbladder cancer: a case report and literature review.

Harada Y, Mihara K, Amemiya R, et al.

BMC gastroenterology 2022; (22(1)):99 doi:10.1186/s12876-022-02179-z.

Treatment of Resectable Gallbladder Cancer.

Vega EA, Mellado S, Salehi O, et al.

Cancers 2022; (14(6)) doi:10.3390/cancers14061413.

Advanced Bile Duct Cancers: A Focused Review on Current and Emerging Systemic Treatments.

Cowzer D, Harding JJ

Cancers 2022; (14(7)) doi:10.3390/cancers14071800.

Preoperative Management of Perihilar Cholangiocarcinoma.

Ellis RJ, Soares KC, Jarnagin WR

Cancers 2022; (14(9)) doi:10.3390/cancers14092119.

Preoperative cachexia index can predict the prognosis of extrahepatic biliary tract cancer after resection.

Hamura R, Haruki K, Shirai Y, et al.

Surgical oncology 2022; (44()):101825 doi:10.1016/j.suronc.2022.101825.

Genomic mutation characteristics and prognosis of biliary tract cancer.

Guo L, Zhou F, Liu H, et al.

American journal of translational research 2022; (14(7)):4990-5002.

Comprehensive clinicopathological and genomic profiling of gallbladder cancer reveals actionable targets in half of patients.

de Bitter TJJ, de Reuver PR, de Savornin Lohman EAJ, et al.

NPJ precision oncology 2022; (6(1)):83 doi:10.1038/s41698-022-00327-y.

Average treatment effect of facility hepatopancreatobiliary malignancy case volume on survival of patients with nonoperatively managed hepatobiliary malignancies.

Elshami M, Ahmed FA, Hue JJ, et al.

Surgery 2023; (173(2)):289-298 doi:10.1016/j.surg.2022.10.011.

Gallbladder Cancer: Current Multimodality Treatment Concepts and Future Directions.

Sturm N, Schuhbaur JS, Hüttner F, et al.

Cancers 2022; (14(22)) doi:10.3390/cancers14225580.

Addition of trastuzumab emtansine (T-DM1) in a human epidermal growth factor receptor 2-overexpressed metastatic carcinoma of the gallbladder patient to enhance survival: A case study.

Lavingia V, Thummar V, Mehta P

SAGE open medical case reports 2022; (10()):2050313X221137447 doi:10.1177/2050313X221137447.

Pixel-Level Clustering of Hematoxylin-Eosin-Stained Sections of Mouse and Human Biliary Tract Cancer.

Inoue H, Aimono E, Kasuga A, et al.

Biomedicines 2022; (10(12)) doi:10.3390/biomedicines10123133.

Cost-effectiveness analysis of durvalumab plus chemotherapy as first-line treatment for biliary tract cancer.

Ye ZM, Xu Z, Li H, Li Q

Frontiers in public health 2023; (11()):1046424 doi:10.3389/fpubh.2023.1046424.

Robotic Systematic Portal Lymphadenectomy. Description of Surgical Technique.

Younos A, Touadi M, Ross S, Sucandy I

The American surgeon 2023; (89(8)):3603-3604 doi:10.1177/00031348231161079.

Improving quality of life in patients with rare autoimmune liver diseases by structured peer-delivered support (Q.RARE.LI): study protocol for a transnational effectiveness-implementation hybrid trial.

Uhlenbusch N, Bal A, Balogh B, et al.

BMC psychiatry 2023; (23(1)):193 doi:10.1186/s12888-023-04669-0.

Fluorescence In Situ Hybridization in Primary Diagnosis of Biliary Strictures: A Single-Center Prospective Interventional Study.

Zoundjiekpon VD, Falt P, Zapletalova J, et al.

Biomedicines 2023; (11(3)) doi:10.3390/biomedicines11030755.

Role of neoadjuvant chemoradiotherapy in liver transplantation for unresectable perihilar cholangiocarcinoma: multicentre, retrospective cohort study.

Hoogwater FJH, Kuipers H, de Meijer VE, et al.

BJS open 2023; (7(2)) doi:10.1093/bjsopen/zrad025.

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial.

Kelley RK, Ueno M, Yoo C, et al.

Lancet (London, England) 2023; (401(10391)):1853-1865 doi:10.1016/S0140-6736(23)00727-4.

Practice patterns in diagnostics, staging, and management strategies of gallbladder cancer among Nordic tertiary centers.

Takala S, Lassen K, Søreide K, et al.

Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society 2023; (112(3)):147-156 doi:10.1177/14574969231181228.

Paradigm shift of chemotherapy and systemic treatment for biliary tract cancer.

Leowattana W, Leowattana T, Leowattana P

World journal of gastrointestinal oncology 2023; (15(6)):959-972 doi:10.4251/wjgo.v15.i6.959.

Trends in hospital volume and operative mortality in hepato-biliary surgery in Veneto region, Italy.

Guglielmi A, Tripepi M, Salmaso L, et al.

Updates in surgery 2023; (75(7)):1949-1959 doi:10.1007/s13304-023-01574-9.

NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023.

Benson AB, D'Angelica MI, Abrams T, et al.

Journal of the National Comprehensive Cancer Network : JNCCN 2023; (21(7)):694-704 doi:10.6004/jnccn.2023.0035.

Investigation of the accuracy of magnetic resonance cholangiography and multi-slice spiral computed tomography in the diagnosis of cholangiocarcinoma.

Ke C, Yang T, Huang G, Gu C

Journal of gastrointestinal oncology 2023; (14(3)):1496-1503 doi:10.21037/jgo-22-1294.

Robotic Type 3B Klatskin Tumor Resection: Technique of Unification Ductoplasty for Roux-en-Y Biliary Reconstruction.

Younos A, Ross S, Sucandy I

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2023; (27(11)):2662-2664 doi:10.1007/s11605-023-05769-8.

Robotic Klatskin Type 3A Resection with Biliary Reconstruction: Description of Surgical Technique and Outcomes of Initial Series.

Sucandy I, Younos A, Lim-Dy A, et al.

Annals of surgical oncology 2023; (30(13)):8559-8560 doi:10.1245/s10434-023-14256-y.

Open injury, robotic repair-moving ahead! Total robotic Roux-en-Y hepaticojejunostomy for post-open cholecystectomy Bismuth type 2 biliary stricture using indocyanine green dye.

Rathore KS, Varshney P, Soni SC, et al.

Journal of minimally invasive surgery 2023; (26(3)):151-154 doi:10.7602/jmis.2023.26.3.151.

Significant CA 19-9 elevation in IgG4-related autoimmune pancreatitis - A diagnostic dilemma.

Farrukh L, Akhtar MF, Waqar HH, Peredo-Wende R

The American journal of the medical sciences 2024; (367(1)):67-71 doi:10.1016/j.amjms.2023.09.016.

Clinical Outcomes of Robotic Resection for Perihilar Cholangiocarcinoma: A First, Multicenter, Trans-Atlantic, Expert-Center, Collaborative Study.

Sucandy I, Marques HP, Lippert T, et al.

Annals of surgical oncology 2024; (31(1)):81-89 doi:10.1245/s10434-023-14307-4.

Primary Sclerosing Cholangitis-Associated Cholangiocarcinoma: From Pathogenesis to Diagnostic and Surveillance Strategies.

Catanzaro E, Gringeri E, Burra P, Gambato M

Cancers 2023; (15(20)) doi:10.3390/cancers15204947.

Clinical approach to indeterminate biliary strictures: Clinical presentation, diagnosis, and workup.

Yadlapati S, Mulki R, Sánchez-Luna SA, et al.

World journal of gastroenterology 2023; (29(36)):5198-5210 doi:10.3748/wjg.v29.i36.5198.

Durvalumab: A Review in Advanced Biliary Tract Cancer.

Fung S, Syed YY

Targeted oncology 2023; (18(6)):965-972 doi:10.1007/s11523-023-01007-y.

Utilization of Multiorgan Radiomics to Predict Future Liver Remnant Hypertrophy After Portal Vein Embolization: Another Tool for the Toolbox?

Dixon MEB, Pappas SG

Annals of surgical oncology 2024; (31(2)):705-708 doi:10.1245/s10434-023-14659-x.

Current Standards, Multidisciplinary Approaches, and Future Directions in the Management of Extrahepatic Cholangiocarcinoma.

Wheless M, Agarwal R, Goff L, et al.

Current treatment options in oncology 2024; (25(1)):127-160 doi:10.1007/s11864-023-01153-5.

Preoperative Myosteatosis and Prognostic Nutritional Index Predict Survival in Older Patients With Resected Biliary Tract Cancer.

Utsumi M, Inagaki M, Kitada K, et al.

Cancer diagnosis & prognosis 2024; (4(2)):147-156 doi:10.21873/cdp.10301.

Current Status of Targeted Therapy for Biliary Tract Cancer in the Era of Precision Medicine.

Mie T, Sasaki T, Okamoto T, et al.

Cancers 2024; (16(5)) doi:10.3390/cancers16050879.

Carbohydrate Antigen (CA 19-9) Surge: Unraveling the Enigma of Elevated Levels in the Setting of Benign Etiologies.

Ansari N, Ozgur SS, Besada D, et al.

Cureus 2024; (16(4)):e57469 doi:10.7759/cureus.57469.

Recent Advancement in Diagnosis of Biliary Tract Cancer through Pathological and Molecular Classifications.

Lee SH, Song SY

Cancers 2024; (16(9)) doi:10.3390/cancers16091761.

Efficacy and safety of irreversible electroporation in unresectable perihilar cholangiocarcinoma: a systematic review and meta-analysis.

Scrofani AR, Valvano M, Lancellotta V, et al.

The British journal of radiology 2024; (97(1160)):1413-1422 doi:10.1093/bjr/tqae107.

Prognostic value of FGFR2 alterations in patients with iCCA undergoing surgery or systemic treatments: A meta-analysis.

Niu S, Zhang Y, Li Z, Wang T

Liver international : official journal of the International Association for the Study of the Liver 2024; (44(9)):2208-2219 doi:10.1111/liv.15984.

Biliary tract cancer.

Søreide K, Dopazo C, Berrevoet F, et al.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2025; (51(6)):108489 doi:10.1016/j.ejso.2024.108489.

CA 19-9 Surveillance Detects Recurrences Early and Contributes to Improvement in Survival in Resected Ampullary Cancers: Analysis of 572 Cases.

Bhandare MS, Varty GP, Reddy Obili RC, et al.

Annals of surgery 2026; (283(2)):286-296 doi:10.1097/SLA.0000000000006419.

Comparison of liver venous deprivation with portal vein embolization alone in patients undergoing major liver resection: a systematic review and meta-analysis.

Yang L, Yang M, Wang T, et al.

HPB : the official journal of the International Hepato Pancreato Biliary Association 2024; (26(11)):1329-1338 doi:10.1016/j.hpb.2024.07.409.

Feasibility Assessment of Robotic Major Hepatectomy and Bile Duct Resection in Klatskin Type IIIB Tumor with Concomitant Gallbladder Cancer.

Jang EJ, Kim KW

Annals of surgical oncology 2024; (31(12)):7898-7899 doi:10.1245/s10434-024-16006-0.

Cost-effectiveness of pembrolizumab plus chemotherapy vs. chemotherapy as first-line treatment for advanced biliary tract cancer in China and the US.

Luo X, Cai T, Wu J, et al.

Frontiers in pharmacology 2024; (15()):1393559 doi:10.3389/fphar.2024.1393559.

Expression of the large amino acid transporter SLC7A5/LAT1 on immune cells is enhanced in primary sclerosing cholangitis-associated cholangiocarcinoma and correlates with poor prognosis in cholangiocarcinoma.

Branchi V, Hosni R, Kiwitz L, et al.

Human pathology 2024; (153()):105670 doi:10.1016/j.humpath.2024.105670.

The volume-outcome relationship for pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension.

Heuts S, Kawczynski MJ, Leus A, et al.

The European respiratory journal 2025; (65(2)) doi:10.1183/13993003.01865-2024.

Clinical significance of CA 19-9 elevation during postoperative surveillance for extrahepatic bile duct cancer: a nomogram-based approach for the prediction of short-term recurrence.

Kwon YJ, Min JH, Hwang JA, et al.

HPB : the official journal of the International Hepato Pancreato Biliary Association 2025; (27(2)):195-205 doi:10.1016/j.hpb.2024.10.015.

Minimum proportion of future liver remnant in safe major hepatopancreatoduodenectomy.

Umemura K, Shimizu A, Notake T, et al.

Annals of gastroenterological surgery 2025; (9(1)):188-198 doi:10.1002/ags3.12850.

ESMO Clinical Practice Guideline interim update on the management of biliary tract cancer.

Vogel A, Ducreux M,

ESMO open 2025; (10(1)):104003 doi:10.1016/j.esmoop.2024.104003.

An Unusual Case of Intrahepatic Stone Masquerading as Cholangiocarcinoma.

Williams AS, Sikes MA, Liu S

ACG case reports journal 2025; (12(2)):e01607 doi:10.14309/crj.0000000000001607.

Klatskin tumor - A case report of hilar cholangiocarcinoma with hepatic metastasis.

Mirzaei S, Motaghed Z, Shokri S, Shafeghat F

International journal of surgery case reports 2025; (128()):111051 doi:10.1016/j.ijscr.2025.111051.

Chinese expert consensus on the clinical application of molecular diagnostics in hepatobiliary cancers (2024 edition).

Ainiwaer A, Cheng J, Lang R, et al.

Liver research 2024; (8(4)):195-206 doi:10.1016/j.livres.2024.11.005.

Liposomal irinotecan for previously treated patients with biliary tract cancer: A pooled analysis of NIFTY and NALIRICC trials.

Yoo C, Saborowski A, Hyung J, et al.

Journal of hepatology 2025; (83(4)):909-916 doi:10.1016/j.jhep.2025.03.013.

Predicting treatment response to systemic therapy in advanced gallbladder cancer using multiphase enhanced CT images.

Wu J, Zheng Z, Li J, et al.

European radiology 2025; (35(11)):7410-7420 doi:10.1007/s00330-025-11645-7.

Durvalumab plus chemotherapy in advanced biliary tract cancer: 3-year overall survival update from the phase III TOPAZ-1 study.

Oh DY, He AR, Qin S, et al.

Journal of hepatology 2025; (83(5)):1092-1101 doi:10.1016/j.jhep.2025.05.003.

Anti-Human Epidermal Growth Factor Receptor-2 Therapies in Biliary Tract Cancers: A Meta-Analysis on Disease Location, Human Epidermal Growth Factor Receptor-2 Status, and Survival Outcomes.

Camera S, Rimini M, Foti S, et al.

Oncology 2026; (104(3)):306-318 doi:10.1159/000545308.

Factors Associated With Depression and Anxiety in People With Rare Diseases During COVID-19: A Cross-Sectional Study.

Inhestern L, Schwab de la O A, Zybarth D, et al.

Depression and anxiety 2025; (2025()):9002779 doi:10.1155/da/9002779.

Comparison of clinical features by primary site in patients with biliary tract cancer who received gemcitabine-based chemotherapy: an exploratory analysis of JCOG1113.

Suzuki Y, Ikeda M, Mizusawa J, et al.

International journal of clinical oncology 2025; (30(10)):2053-2062 doi:10.1007/s10147-025-02834-x.

Short-term and long-term outcomes of hepatopancreatoduodenectomy for extrahepatic cholangiocarcinoma and gallbladder carcinoma: A systematic review and meta-analysis with meta-regression.

Hajibandeh S, Hajibandeh S, Raza SS, et al.

Surgery 2025; (186()):109593 doi:10.1016/j.surg.2025.109593.

Leveraging Multimodal Foundation Models in Biliary Tract Cancer Research.

Singh Y, Andersen JB, Hathaway QA, et al.

Tomography (Ann Arbor, Mich.) 2025; (11(9)) doi:10.3390/tomography11090096.

T3 gallbladder cancer: surgical outcomes according to the mode of tumor spread and treatment considerations for oncological resectability.

Kawachi Y, Sakata J, Nomura T, et al.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2025; (51(12)):110457 doi:10.1016/j.ejso.2025.110457.

KRAS Mutation Allele Frequency Dynamics in Plasma Extracellular Vesicles: Association with Survival in Localized Pancreatic Adenocarcinoma.

Chopra A, He HZ, Milosevic J, et al.

Annals of surgical oncology 2026; (33(2)):1605-1615 doi:10.1245/s10434-025-18633-7.

Liquid biopsy in biliary tract cancers: early diagnosis, precision therapy, and prognostic evaluation.

Wu G, Xu X, Zhang H, et al.

Frontiers in oncology 2025; (15()):1705162 doi:10.3389/fonc.2025.1705162.

Advancing systemic therapy for biliary tract cancer: current strategies and emerging paradigms.

Choucair K, Chamseddine S, Azmi A, Philip PA

Frontiers in oncology 2026; (16()):1769447 doi:10.3389/fonc.2026.1769447.